Clinical ResearchVascular FunctionSustained Benefits in Vascular Function Through Flavanol-Containing Cocoa in Medicated Diabetic Patients: A Double-Masked, Randomized, Controlled Trial
Abbreviations and Acronyms
Cited by (0)
Mars Inc., McLean, Virginia supported this study with an unrestricted grant. Drs. Kelm (Ke 405/5-1), Rassaf (Ra 969/4-1), and Merx (ME 1821/3-1) are supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany. Drs. Balzer and Rassaf are funded by an intramural funding program of the University Hospital RWTH Aachen (START-Verbundantrag: Kardiovaskuläre Dysfunktion durch Kalk und Niereninsuffizienz, Teilprojekt P5). Dr. Lauer is supported by the Hans und Gertie Fischer-Stiftung, Essen, Germany, and Dr. Heiss is supported by an award from the American Heart Association (0525078Y). Dr. Schroeter is employed by Mars Symbioscience, a division of Mars Inc. Mars Inc. provided the instant cocoa beverage powder for the preparation of cocoa drinks. Furthermore, Mars Inc. had no role in the design, conduct, and analysis of the study. Drs. Balzer and Rassaf contributed equally to this work.